ArticleJournal of pharmaceutical health care and sciences2025
Disproportionality analysis of adverse events in advanced lung cancer treated with atezolizumab plus platinum-based combination chemotherapy.
Katsuyuki Hazama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.